Cargando…
Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer
We report a case of long-term (9 years) response to 4th-line endocrine treatment with fulvestrant given for advanced breast cancer after no or poor response to prior endocrine therapies. Complete remission was achieved with full dose and maintained even after dose reduction due to unanticipated inte...
Autores principales: | Hawle, H., Hess, D., Mueller, A., Thuerlimann, B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919988/ https://www.ncbi.nlm.nih.gov/pubmed/20740185 http://dx.doi.org/10.1159/000313838 |
Ejemplares similares
-
Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy
por: Hara, Fumikata, et al.
Publicado: (2010) -
Transesophageal Echocardiographically-Confirmed Pulmonary Vein Thrombosis in Association with Posterior Circulation Infarction
por: Kinsella, Justin A., et al.
Publicado: (2010) -
Spinal Epidural Hematoma as a Complication of Intravenous Thrombolysis in an Acute Ischemic Stroke Patient
por: Liebkind, Ron, et al.
Publicado: (2010) -
Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation
por: Masago, Katsuhiro, et al.
Publicado: (2010) -
Follicular Thyroid Carcinoma Presenting as a Palpable Head Mass: A Case Report
por: Atkinson, Andrew L., et al.
Publicado: (2010)